Aardvark Therapeutics Ownership | Who Owns Aardvark Therapeutics?


OverviewForecastFinancialsChart

Aardvark Therapeutics Ownership Summary


Aardvark Therapeutics is owned by 4.83% institutional investors, 16.15% insiders, and 79.02% retail investors. Decheng capital is the largest institutional shareholder, holding 19.96% of AARD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.87% of its assets in Aardvark Therapeutics shares.

AARD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAardvark Therapeutics4.83%16.15%79.02%
SectorHealthcare Stocks 50.51%12.37%37.12%
IndustryBiotech Stocks 48.95%12.07%38.98%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Decheng capital3.92M19.96%$14.77M
Citadel advisors1.24M6.33%$4.69M
Laurion capital management lp1.03M5.27%$3.90M
Blackrock funding, inc. /de792.57K4.04%$2.99M
Vanguard group717.43K3.30%$9.42M
Geode capital management309.45K1.58%$1.17M
Adage capital partners gp300.00K1.53%$1.13M
State street199.32K1.02%$751.44K
Two sigma investments, lp163.35K0.83%$615.85K
Ubs group157.89K0.80%$595.24K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Decheng capital3.92M2.23%$14.77M
Laurion capital management lp1.03M0.17%$3.90M
Prelude capital management30.64K0.01%$115.50K
Cantor fitzgerald, l. p.66.68K0.00%$251.39K
Bridgeway capital management27.00K0.00%$101.79K
Adage capital partners gp300.00K0.00%$1.13M
Xtx topco19.91K0.00%$75.08K
Eversource wealth advisors2.55K0.00%$39.04K
China universal asset management3.86K0.00%$14.57K
Woodline partners lp72.43K0.00%$273.06K

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp300.00K0.00%300.00K
Vanguard group717.43K0.00%161.71K
Aqr capital management134.50K0.00%134.50K
Ubs group157.89K0.00%131.05K
Vanguard fiduciary trust83.21K0.00%83.21K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---800.19K
Braidwell lp---500.00K
Millennium management98.33K0.00%-385.01K
Tfg asset management gp---316.62K
Suvretta capital management---312.50K

New Positions

HolderShares% AssetsChangeValue
Aqr capital management134.50K0.00%134.50K$507.05K
Vanguard fiduciary trust83.21K0.00%83.21K$313.70K
Woodline partners lp72.43K0.00%72.43K$273.06K
Prelude capital management30.64K0.01%30.64K$115.50K
Two sigma advisers, lp25.70K0.00%25.70K$341.55K

Sold Out

HolderChange
Advisory services network-9.00
Wealth preservation advisors-31.00
Sterling capital management-233.00
Mai capital management-276.00
Amalgamated bank-400.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202630-53.85%1,054,701-90.19%40.20%20-59.18%6-33.33%
Dec 31, 202542-12.50%8,303,883-12.23%382.01%31-8.82%5-28.57%
Sep 30, 20254734.29%8,416,251-5.60%382.30%3310.00%7133.33%
Jun 30, 20253529.63%8,915,7972.64%410.95%3011.11%3-
Mar 31, 202527-8,686,452-65-27---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv408.67K1.87%-
Vanguard MStar Total Stk Mkt Idx Invest408.67K1.87%-
Vanguard Morn Total Stk Mkt Idx Investor408.67K1.87%-
iShares Russell 2000 ETF297.09K1.36%2.76K
Vanguard Institutional Extnd Mkt Idx Tr140.39K0.64%-
Fidelity Small Cap Index129.52K0.59%2.76K
iShares Biotechnology ETF91.82K0.42%-279.00
Russell 2000 Index Non-Lendable Fund77.22K0.35%77.22K
Russell 2000 Equity Index Fund B77.22K0.35%73.00
Fidelity Extended Market Index64.95K0.30%-1.80K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 11, 2025Sun Nelson Chief Financial OfficerBuy$43.20K
Dec 11, 2025Lee Tien-Li Chief Executive OfficerBuy$101.39K
Sep 15, 2025Lee Tien-Li Chief Executive OfficerBuy$61.82K
Sep 15, 2025Lee Tien-Li Chief Executive OfficerBuy$34.80K
Sep 11, 2025Lee Tien-Li Chief Executive OfficerBuy$46.93K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q42-
2025 Q36-
2025 Q2--
2007 Q31-

AARD Ownership FAQ


Who Owns Aardvark Therapeutics?

Aardvark Therapeutics shareholders are primarily institutional investors at 4.83%, followed by 16.15% insiders and 79.02% retail investors. The average institutional ownership in Aardvark Therapeutics's industry, Biotech Stocks , is 48.95%, which Aardvark Therapeutics falls below.

Who owns the most shares of Aardvark Therapeutics?

Aardvark Therapeutics’s largest shareholders are Decheng capital (3.92M shares, 19.96%), Citadel advisors (1.24M shares, 6.33%), and Laurion capital management lp (1.03M shares, 5.27%). Together, they hold 31.57% of Aardvark Therapeutics’s total shares outstanding.

Does Blackrock own Aardvark Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aardvark Therapeutics.

Who is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested?

Decheng capital is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.23% of its assets in 3.92M Aardvark Therapeutics shares, valued at 14.77M$.

Who is the top mutual fund holder of Aardvark Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aardvark Therapeutics shares, with 1.87% of its total shares outstanding invested in 408.67K Aardvark Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools